Readmissions and repeat procedures after catheter ablation for atrial fibrillation

Cardiology Journal

Volumn 22, Issue 6, 2015, Pages 630-636

  Opolski, Grzegorz ^a   Januszkiewicz, Łukasz ^a   Szczerba, Ewa ^a   Osińska, Bogusława ^b   Rutkowski, Daniel ^b   Kalarus, Zbigniew ^c   Kaźmierczak, Jarosław ^d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b National Health Fund   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Ablation; Atrial fibrillation; Pulmonary vein isolation

Indexed keywords

ABLATION CATHETER; ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY ABLATION; REPEAT PROCEDURE; THROMBOEMBOLISM; CAUSE OF DEATH; CLINICAL TRIAL; EPIDEMIOLOGY; HEART MUSCLE CONDUCTION SYSTEM; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; POLAND; PROCEDURES; RECURRENT DISEASE; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS;

ATRIAL FIBRILLATION; CATHETER ABLATION; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; POLAND; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84988220250     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.a2015.0037     Document Type: Article

References (12)

1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA, 2001; 285: 2370–2375.
2. Kumar S, Walters TE, Halloran K et al. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. The use of coronary intervention for the treatment of ischaemic heart disease in australia. Europace, 2013; 15: 1702–1709. doi: 10.1093/europace/eut162.
3. Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol, 2010; 3: 32–38. doi: 10.1161/circep.109.859116.
4. Camm AJ, Kirchhof P, Lip GY et al. Guidelines ESCCfP. Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace, 2010; 12: 1360–1420. doi: 10.1093/europace/euq350.
5. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol, 2012; 59: 143-149. doi: 10.1016/j.jacc.2011.08.068.
6. Murakawa Y, Nogami A, Shoda M et al. Nationwide survey of catheter ablation for atrial fibrillation: The japanese catheter ablation registry of atrial fibrillation (j-caraf): Report of 1-year follow-up. Circ J, 2014; 78: 1091–1096. doi: 10.1253/circj.CJ-14-0099.
7. Lip GY, Laroche C, Ioachim PM et al. Prognosis and treatment of atrial fibrillation patients by european cardiologists: One year follow-up of the eurobservational research programme-atrial fibrillation general registry pilot phase (eorp-af pilot registry). Eur Heart J, 2014; 35: 3365–3376. doi: 10.1093/eurheartj/ehu374.
8. Ferrero de Loma-Osorio A, Gil-Ortega I, Pedrote-Martinez A, Spanish Catheter Ablation Registry. Spanish catheter ablation registry. 13th official report of the spanish society of cardiology working group on electrophysiology and arrhythmias (2013). Rev Esp Cardiol, 2014; 67: 925–935. doi: 10.1016/j.rec.2014.07.009.
9. Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in medicare beneficiaries. Heart Rhythm, 2009; 6: 1267–127. doi: 10.1016/j.hrthm.2009.06.009.
10. Forleo GB, Tondo C, De Luca L et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace, 2007; 9: 613–620. doi: 10.1093/europace/eum144.
11. Suttorp MJ, Kingma JH, Koomen EM, van’t Hof A, Tijssen JG, Lie KI. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol, 1993; 71: 710–713.
12. Kerr CR, Humphries K. Gender-related differences in atrial fibrillation. J Am Coll Cardiol, 2005; 46: 1307–1308. doi: 10.1016/j.jacc.2005.07.007.